INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Historical Holders from Q1 2014 to Q3 2025

Symbol
IART on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
77.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
72.9M
Holdings value
$1.04B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
205
Number of buys
95
Number of sells
-111
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13.2% $126M 10.3M BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 9.46% +57.5% $90.2M $33.3M 7.35M +58.4% Rubric Capital Management LP 30 Jun 2025
Invesco Ltd. 4.5% -16% $50M -$8.9M 3.49M -15.1% Invesco Ltd. 30 Sep 2025
MORGAN STANLEY 4.3% $42.5M 3.38M Morgan Stanley 30 Jun 2025

Institutional Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 72.9M $1.04B -$4.25M $14.33 205
2025 Q2 73.1M $897M -$36.9M $12.27 208
2025 Q1 73.5M $1.62B +$95.4M $21.99 217
2024 Q4 69.3M $1.57B +$40.4M $22.68 221
2024 Q3 68.4M $1.24B -$124M $18.17 221
2024 Q2 71M $2.07B +$112M $29.14 236
2024 Q1 65.9M $2.34B -$71M $35.45 276
2023 Q4 66.9M $2.92B -$77M $43.55 283
2023 Q3 68.8M $2.63B -$14.1M $38.19 261
2023 Q2 68.8M $2.83B -$178M $41.13 276
2023 Q1 72.8M $4.18B -$120M $57.41 276
2022 Q4 74.9M $4.2B +$360M $56.07 274
2022 Q3 73.9M $3.13B +$18.8M $42.36 267
2022 Q2 73.1M $3.95B -$58.8M $54.03 274
2022 Q1 74.7M $4.8B -$193M $64.26 270
2021 Q4 77.4M $5.18B +$22.6M $66.99 266
2021 Q3 76.8M $5.26B +$143M $68.48 249
2021 Q2 74.8M $5.1B +$63.7M $68.24 256
2021 Q1 73.8M $5.1B -$20M $69.09 251
2020 Q4 74.1M $4.81B +$106M $64.92 242
2020 Q3 72.7M $3.43B +$24.6M $47.22 227
2020 Q2 72.2M $3.39B +$38M $46.99 258
2020 Q1 71.5M $3.19B +$34.5M $44.67 247
2019 Q4 70.4M $4.1B +$75.4M $58.28 274
2019 Q3 69M $4.15B -$76.1M $60.07 275
2019 Q2 70.6M $3.94B -$15.8M $55.85 259
2019 Q1 71.1M $3.96B -$9.69M $55.72 253
2018 Q4 71.4M $3.22B -$146M $45.10 240
2018 Q3 73.9M $4.87B +$89.9M $65.87 244
2018 Q2 72.6M $4.67B +$136M $64.41 254
2018 Q1 70.5M $3.9B -$37.4M $55.34 235
2017 Q4 71.4M $3.42B +$94.6M $47.86 216
2017 Q3 69.3M $3.5B +$122M $50.48 210
2017 Q2 65.6M $3.58B +$89.2M $54.51 219
2017 Q1 68.3M $2.88B +$1.53B $42.13 235
2016 Q4 34.4M $2.95B +$111M $85.79 211
2016 Q3 33.3M $2.75B +$50.3M $82.55 229
2016 Q2 33.4M $2.67B +$55.4M $79.78 205
2016 Q1 32.9M $2.22B +$102M $67.36 191
2015 Q4 31.3M $2.12B +$35.2M $67.78 180
2015 Q3 30.9M $1.84B +$220M $59.55 186
2015 Q2 27.1M $1.83B -$24.3M $67.37 185
2015 Q1 27.6M $1.7B +$73.6M $61.65 168
2014 Q4 26.4M $1.43B +$6.25M $54.23 157
2014 Q3 26.3M $1.3B +$5.5M $49.64 140
2014 Q2 26.2M $1.23B +$22.7M $47.06 143
2014 Q1 25.7M $1.18B +$19M $45.99 139